Down-regulation of IFNAR1 in immune and tumor cells as a mechanism of resistance to IFN in cancers has, perhaps deservedly, garnered most interest in this context as cell surface IFNAR1 levels are key for type I IFN anti-proliferative effects (73). The gene discussed is IFNAR1; the disease is cancer.